Bristol-Myers Squibb Company Financial Ratios — BMY Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	23.42	13.25	17.81	13.36	10.75	29.28	7.21	38.18	10.48	-20.16	18.96	18.88	26.53	-39.1	40.53
Return on Assets (%)	11.58	5.69	6.88	5.54	4.78	13.62	2.99	14.36	4.17	-7.26	6.14	6.14	8.36	-9.53	7.72
Return on Capital (%)	10.68	- -	12.21	9.28	7.48	20.53	5.02	24.44	6.42	- -	9.5	9.54	12.78	- -	12.73
Return on Invested Capital (%)	23.52	- -	11.69	6.26	6.1	15.51	3.06	20.59	4.92	- -	8.64	9.75	10.86	- -	15.61
Gross Margin (%)	73.65	73.84	71.81	75.24	76.39	74.42	71.05	71.34	69.1	72.31	78.57	78.04	76.24	71.08	71.08
EBITDA Margin (%)	34.2	26.18	22.55	13.74	12.72	25.33	20.39	25.61	23.18	29.56	41.44	41.99	39.89	32.06	36.8
Operating Margin (%)	31.24	22.31	17.89	10.79	10.45	23.36	16.59	22.79	16.5	5.15	18.4	19.72	18.21	12.19	28.48
Incremental Operating Margin (%)	39.03	74.66	80.99	240.51	2.35	97.98	-80.95	94.9	-23.07	-12.97	164.13	-250.88	78.84	-70.07	-7,463.81
Pretax Margin (%)	32.86	13.28	17.64	14.99	12.54	30.45	24.7	26.45	19.03	-16.16	17.46	16.71	18.75	-17.35	19.35
Profit Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Net Income to Common Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Effective Tax Rate (%)	24.65	- -	10.76	14.78	21.47	23.8	81	17.11	30.45	- -	13.39	17.74	4.74	- -	24.36
Dvd Payout Ratio (%)	33.09	75.15	88.91	116.75	145.96	55.89	273.28	52.53	76.96	-45.4	62.5	72.83	58.9	-54.53	71.49
Sustainable Growth Rate (%)	15.67	3.29	1.98	-2.24	-4.94	12.92	-12.5	18.12	2.41	-29.32	7.11	5.13	10.91	-60.43	11.56

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
ST Debt	115	826	359	590	139	992	987	1,703	3,479	2,504	5,117	4,400	3,281	2,227	2,463
LT Debt	5,376	6,568	7,981	7,242	6,550	5,716	6,975	5,646	44,059	49,169	40,479	36,317	38,183	48,973	44,676
Total Debt/EBITDA	0.76	1.6	2.26	3.59	3.18	1.36	1.88	1.27	7.84	4.11	2.37	2.1	2.31	3.31	2.66
Net Debt/EBITDA	-0.04	1.24	1.29	1.04	2.04	0.5	0.6	0.08	5.67	2.87	1.59	1.56	1.58	2.54	1.97
Total Debt/EBIT	0.83	1.88	2.85	4.57	3.87	1.48	2.31	1.43	11.02	23.59	5.34	4.47	5.06	8.7	3.43
Net Debt/EBIT	-0.04	1.46	1.62	1.32	2.49	0.54	0.74	0.09	7.97	16.5	3.58	3.32	3.45	6.68	2.54
EBITDA to Interest Expense	50.1	25.35	18.56	10.74	11.45	29.47	21.61	31.57	9.24	8.85	14.41	15.73	15.4	7.95	9.38
EBITDA-CapEx/Interest Expense	47.57	22.34	15.86	8.15	11.45	29.47	21.61	31.57	9.24	8.85	14.41	15.73	15.4	7.95	9.38
EBIT to Interest Expense	45.77	21.6	14.73	8.44	9.4	27.18	17.59	28.09	6.58	1.54	6.4	7.39	7.03	3.02	7.26
Interest Expense	145	182	199	203	184	167	196	183	656	1,420	1,334	1,232	1,166	1,947	1,891
Common Equity/Total Assets	48.4	37.95	39.27	44.01	44.94	47.99	34.99	40.1	39.71	31.92	32.88	32.08	30.93	17.64	20.52
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	25.17	31.23	33.85	31.74	31.02	24.79	35.21	26.29	44.4	54.9	49.61	50.56	53.82	72.46	68.06
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	25.71	35.16	35.37	34.33	31.68	29.1	40.19	34.22	47.9	57.7	55.88	56.68	58.44	75.75	71.81
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
Net Debt to Equity	-1.8	42.07	31.2	15.09	29.84	15.12	21.45	3.1	66.52	95.38	84.91	97.04	96.01	239.83	188.6
Net Debt/Capital (%)	-1.83	29.61	23.78	13.11	22.98	13.13	17.66	3.01	39.58	48.17	45.21	48.15	47.59	68.66	62.96
EBITDA	7,265	4,613	3,694	2,181	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
EBITDA-CapEx	6,898	4,065	3,157	1,655	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
Operating Income (Loss)	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.12	0.34	0.36	0.88	0.53	0.72	0.71	0.82	0.84	0.86	0.79	0.42	0.55	0.46	0.46
Current Ratio	1.97	1.15	1.52	1.73	1.3	1.55	1.55	1.66	1.6	1.58	1.52	1.25	1.43	1.25	1.26
Quick Ratio	1.6	0.71	0.63	1.28	1.07	1.35	1.37	1.36	1.26	1.42	1.36	1.06	1.24	1.06	1.08
CFO/Avg Current Liab	0.67	0.86	0.34	0.3	0.26	0.36	0.57	0.7	0.57	0.75	0.79	0.6	0.63	0.66	0.6
Common Equity/Total Assets	48.4	37.95	39.27	44.01	44.94	47.99	34.99	40.1	39.71	31.92	32.88	32.08	30.93	17.64	20.52
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	25.17	31.23	33.85	31.74	31.02	24.79	35.21	26.29	44.4	54.9	49.61	50.56	53.82	72.46	68.06
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	25.71	35.16	35.37	34.33	31.68	29.1	40.19	34.22	47.9	57.7	55.88	56.68	58.44	75.75	71.81
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
CFO/Total Liabilities	28.3	31.18	15.18	16.78	12.15	17.62	24.3	33.88	10.49	17.43	22.11	19.89	21.1	19.93	19.79
CFO/CapEx	13.19	12.67	6.6	5.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	6.14	5.43	4.98	6.1	6.92	6.79	5.98	5.93	3.44	3.11	3.74	4.37	3.61	2.93	3.46

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	18.88	8.9	9.64	8.38	6.56	5.78	5.12	5.02	4.71	6.21	6.1	5.72	5.28	5.4	5.18
Days Sales Outstanding	19.33	40.99	37.85	43.56	55.63	63.15	71.34	72.67	77.57	58.78	59.8	63.77	69.07	67.61	70.45
Inventory Turnover	4.33	3.03	2.93	2.57	2.81	4.04	5	5.48	2.94	3.7	4.77	4.57	4.28	5.35	5.31
Days Inventory Outstanding	84.37	120.39	124.66	141.93	129.84	90.42	73.04	66.63	123.99	98.7	76.54	79.83	85.35	68.19	68.71
Accounts Payable Turnover	2.52	2.03	1.87	1.58	1.76	3.09	3.04	3.14	5.15	3.7	3.52	3.47	3.5	4.04	3.92
Accounts Payable Turnover Days	144.85	179.58	194.82	230.57	207.14	118.12	120.21	116.31	70.82	98.53	103.74	105.29	104.35	90.32	93.1
Cash Conversion Cycle	-41.15	-18.21	-32.31	-45.08	-21.67	35.45	24.17	22.98	130.73	58.95	32.6	38.31	50.07	45.48	46.06
Inventory to Cash Days	-65.04	-79.39	-86.81	-98.38	-74.21	-27.28	-1.71	6.04	-46.42	-39.92	-16.75	-16.05	-16.28	-0.58	1.74
Inventories	1,384	1,657	1,498	1,560	1,221	1,241	1,166	1,195	4,293	2,074	2,095	2,339	2,662	2,557	2,690
Raw Materials	260	271	250	204	199	264	273	116	172	207	350	464	- -	- -	- -
Work In Process	646	814	757	856	868	988	931	1,152	3,267	2,015	2,111	1,850	- -	- -	- -
Finished Goods	478	572	491	500	381	310	384	356	2,227	932	543	509	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,080	-909	-484	2,662	2,557	2,690

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	59,379	53,122	87,219	97,577	114,260	97,244	99,580	84,416	143,015	137,769	134,240	149,296	103,698	114,760	109,809
- Cash & Cash Equivalents	5,776	1,656	3,586	5,571	2,385	4,237	5,421	6,911	12,346	14,546	13,979	9,123	11,464	10,346	10,209
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	-89	15	82	131	158	170	106	96	100	60	60	57	55	53	33
+ Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
Enterprise Value	56,048	57,702	91,116	98,105	116,837	97,772	100,836	83,102	175,260	173,052	162,675	180,817	132,937	155,154	146,308
Total Capital	21,358	21,032	23,576	22,815	21,113	23,055	19,809	21,476	99,236	89,555	81,602	71,835	70,949	67,588	65,645
Total Debt/Capital (%)	25.71	35.16	35.37	34.33	31.68	29.1	40.19	34.22	47.9	57.7	55.88	56.68	58.44	75.75	71.81
Total Debt / EV	0.1	0.13	0.09	0.08	0.06	0.07	0.08	0.09	0.27	0.3	0.28	0.23	0.31	0.33	0.32
EV/Sales	2.64	3.27	5.56	6.18	7.06	5.03	4.85	3.68	6.7	4.07	3.51	3.92	2.95	3.21	3.04
EV/EBITDA	7.71	12.51	24.67	44.98	55.48	19.87	23.8	14.38	28.92	13.77	8.46	9.33	7.4	10.02	8.25
EV/EBIT	8.44	14.67	31.09	57.24	67.54	21.54	29.25	16.16	40.63	79.02	19.06	19.86	16.22	26.36	10.66
EV/Cash Flow to Firm	11.32	8.09	24.48	29.54	51.94	30.7	18.98	11.51	20.22	10.88	9.37	12.84	8.88	8.99	9.39
EV/Free Cash Flow to Firm	10.54	7.51	21.39	25.5	51.94	30.7	18.98	11.51	20.22	10.88	9.37	12.84	8.88	8.99	9.39
Diluted Market Cap	60,507	55,012	88,335	98,580	115,498	98,179	101,235	85,091	109,893	140,064	139,976	154,405	106,622	114,647	109,984
Diluted Enterprise Value	60,133	60,765	93,171	100,972	119,960	100,820	103,882	85,625	145,185	177,251	171,653	186,056	136,677	155,554	146,947
EV per Share	33.26	35.4	55.52	59.35	70.34	58.76	62.05	51.17	78.66	77.92	75.56	87.14	65.78	76.47	71.87
TTM Sales	21,244	17,621	16,385	15,879	16,560	19,427	20,776	22,561	26,145	42,518	46,385	46,159	45,006	48,300	48,195
TTM EBITDA	7,265	4,613	3,694	2,181	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
TTM Operating Income	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724
TTM Cash Flow to Firm	4,949	7,136	3,723	3,321	2,249	3,185	5,312	7,218	8,666	15,911	17,362	14,079	14,971	17,266	15,586
TTM Free Cash Flow to Firm	5,316	7,684	4,260	3,847	2,249	3,185	5,312	7,218	8,666	15,911	17,362	14,079	14,971	17,266	15,586

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	11.62	7.35	21.64	26.83	54.87	32.11	19.19	12.04	13.39	9.97	8.64	11.82	7.69	7.55	7.77
EV/EBIT	8.44	14.67	31.09	57.24	67.54	21.54	29.25	16.16	40.63	79.02	19.06	19.86	16.22	26.36	10.66
Enterprise Value	56,048	57,702	91,116	98,105	116,837	97,772	100,836	83,102	175,260	173,052	162,675	180,817	132,937	155,154	146,308
Low Price	24.97	30.64	32.5	46.3	51.82	49.03	46.01	46.94	42.48	45.76	53.22	60.86	48.25	39.35	42.52
EV/Sales	2.64	3.27	5.56	6.18	7.06	5.03	4.85	3.68	6.7	4.07	3.51	3.92	2.95	3.21	3.04
EV/EBITDA	7.71	12.51	24.67	44.98	55.48	19.87	23.8	14.38	28.92	13.77	8.46	9.33	7.4	10.02	8.25
Price/Earnings	16.15	27.77	34.09	48.81	73.27	21.91	100.1	17.25	31.82	- -	19.19	24.22	13.23	- -	15.55
Price/Earnings Average	13.26	28.37	28.13	43.17	68.73	23.69	94.03	19.18	24.88	-15.19	19.39	24.52	16.19	-11.24	14.54
Price/Earnings High	16.24	30.96	34.95	51.07	75.49	28.91	107.98	23.25	32.1	-17.12	21.47	27.42	19.38	-13.84	18.26
Price/Earnings Low	11.44	26.11	20.85	38.28	55.2	18.38	75.16	15.58	21.06	-11.46	16.38	20.49	12.44	-8.91	12.26
Price/Book Value	3.72	3.9	5.76	6.57	8.01	6.01	8.48	6.02	2.77	3.64	3.73	4.81	3.52	7.03	5.94
Price/Book Value Average	3.06	3.98	4.75	5.81	7.51	6.5	7.97	6.69	2.17	3.56	3.77	4.86	4.31	6.16	5.56
Price/Book Value High	3.74	4.35	5.9	6.87	8.25	7.93	9.15	8.11	2.8	4.01	4.18	5.44	5.16	7.59	6.98
Price/Book Value Low	2.64	3.67	3.52	5.15	6.03	5.04	6.37	5.43	1.83	2.69	3.19	4.07	3.31	4.89	4.69
Price/Tangible Book Value	8.19	-19.04	15.19	16.07	19.15	12.28	27.15	13.19	-4.1	-3.81	-4.91	-5.65	-5.39	-3.95	-4.85
Price/Tangible Book Value Average	6.73	-19.45	12.54	14.21	17.96	13.28	25.5	14.66	-3.21	-3.72	-4.96	-5.71	-6.6	-3.47	-4.54
Price/Tangible Book Value High	8.24	-21.23	15.58	16.82	19.73	16.21	29.28	17.77	-4.14	-4.2	-5.49	-6.39	-7.9	-4.27	-5.7
Price/Tangible Book Value Low	5.81	-17.9	9.29	12.6	14.43	10.31	20.38	11.91	-2.72	-2.81	-4.19	-4.78	-5.07	-2.75	-3.82
Price/Sales	2.82	3.09	5.33	6.16	6.92	5.03	4.85	3.76	4.19	3.29	2.89	3.32	2.36	2.37	2.28
Price/Sales Average	2.32	3.16	4.4	5.45	6.5	5.44	4.56	4.18	3.27	3.22	2.92	3.36	2.89	2.08	2.13
Price/Sales High	2.84	3.44	5.47	6.45	7.13	6.63	5.23	5.07	4.22	3.63	3.24	3.76	3.46	2.56	2.67
Price/Sales Low	2	2.9	3.26	4.83	5.22	4.22	3.64	3.4	2.77	2.43	2.47	2.81	2.22	1.65	1.79
Price/Cash Flow	12.38	7.84	24.65	31.07	54.48	31.93	19.11	12.01	13.33	9.97	8.28	11.73	7.66	7.55	7.75
Price/Cash Flow Average	10.16	8.01	20.33	27.48	51.1	34.53	17.95	13.35	10.42	9.75	8.37	11.87	9.37	6.62	7.25
Price/Cash Flow High	12.45	8.74	25.27	32.51	56.12	42.14	20.61	16.19	13.45	10.98	9.27	13.28	11.22	8.15	9.1
Price/Cash Flow Low	8.77	7.37	15.07	24.37	41.04	26.79	14.35	10.85	8.82	7.35	7.07	9.92	7.2	5.25	6.11
Price/Free Cash Flow Average	9.54	7.5	17.85	23.73	51.47	34.72	18.03	13.39	10.46	9.75	8.72	11.96	9.41	6.62	7.26
Price/Free Cash Flow High	11.69	8.19	22.19	28.08	56.53	42.37	20.7	16.23	13.5	10.98	9.66	13.38	11.27	8.15	9.12
Price/Free Cash Flow Low	8.23	6.91	13.23	21.05	41.33	26.94	14.41	10.87	8.86	7.35	7.37	10	7.23	5.25	6.12
EV/Sales Average	2.28	3.41	4.69	5.59	6.74	5.55	4.63	4.18	5.63	4.04	3.61	3.96	3.49	2.93	2.9
EV/Sales High	2.79	3.69	5.75	6.58	7.38	6.74	5.3	5.07	6.87	4.44	3.92	4.35	4.04	3.41	3.44
EV/Sales Low	1.96	3.16	3.55	4.97	5.47	4.34	3.73	3.4	4.97	3.26	3.15	3.42	2.83	2.5	2.56
EV/EBITDA Average	6.66	13.01	20.79	40.67	53.01	21.9	22.71	16.33	24.27	13.68	8.7	9.43	8.74	9.14	7.87
EV/EBITDA High	8.17	14.09	25.52	47.91	58.01	26.61	25.98	19.78	29.63	15.03	9.46	10.35	10.14	10.64	9.35
EV/EBITDA Low	5.74	12.07	15.75	36.19	42.99	17.12	18.28	13.29	21.44	11.04	7.61	8.15	7.1	7.8	6.96
EV/EBIT Average	7.29	15.27	26.2	51.75	64.53	23.75	27.9	18.36	34.1	78.49	19.6	20.07	19.15	24.05	10.17
EV/EBIT High	8.94	16.53	32.16	60.97	70.62	28.85	31.93	22.23	41.62	86.29	21.3	22.04	22.21	28	12.09
EV/EBIT Low	6.28	14.16	19.85	46.05	52.33	18.56	22.46	14.93	30.12	63.39	17.13	17.35	15.57	20.51	9
Last Price	35.24	32.59	53.15	59.03	68.79	58.44	61.28	51.98	64.19	62.03	62.35	71.95	51.31	56.56	53.94
High Price	35.44	36.34	54.49	61.77	70.87	77.12	66.1	70.05	64.75	68.34	69.75	81.44	75.18	61.08	63.33
Enterprise Value Average	48,376	60,024	76,790	88,693	111,636	107,793	96,184	94,378	147,102	171,896	167,284	182,752	156,954	141,589	139,635
Enterprise Value High	59,342	64,987	94,254	104,498	122,177	130,969	110,059	114,295	179,555	188,970	181,849	200,639	181,994	164,838	165,887
Enterprise Value Low	41,700	55,696	58,168	78,926	90,535	84,227	77,413	76,765	129,937	138,820	146,260	157,936	127,568	120,748	123,523

Shares Outstanding	1,685	1,630	1,641	1,653	1,661	1,664	1,625	1,624	2,228	2,221	2,153	2,075	2,021	2,029	2,036
Diluted Weighted Avg Shares	1,717	1,688	1,662	1,670	1,679	1,680	1,652	1,637	1,712	2,258	2,245	2,146	2,078	2,027	2,039
Basic Weighted Avg Shares	1,700	1,670	1,644	1,657	1,667	1,671	1,645	1,633	1,705	2,258	2,153	2,130	2,069	2,027	2,034
Revenue per Share	12.5	10.55	9.97	9.58	9.93	11.63	12.63	13.82	15.33	18.83	21.54	21.67	21.75	23.83	23.69
EBITDA per Share	4.27	2.76	2.25	1.32	1.26	2.94	2.58	3.54	3.55	5.57	8.93	9.1	8.68	7.64	8.72
Operating Income per Share	3.9	2.35	1.78	1.03	1.04	2.72	2.1	3.15	2.53	0.97	3.97	4.27	3.96	2.9	6.75
Basic EPS, GAAP	2.18	1.17	1.56	1.21	0.94	2.67	0.61	3.01	2.02	-3.99	3.25	2.97	3.88	-4.41	3.47
Basic EPS from Cont Ops	3.09	1.5	1.57	1.22	0.98	2.7	0.59	3.03	2.03	-3.98	3.26	2.98	3.89	-4.41	3.47
Diluted EPS, GAAP	2.16	1.16	1.54	1.2	0.93	2.65	0.61	3.01	2.01	-3.99	3.12	2.95	3.86	-4.41	3.46
Diluted EPS from Cont Ops	3.06	1.48	1.55	1.21	0.97	2.68	0.59	3.02	2.02	-3.98	3.12	2.96	3.87	-4.41	3.46
Dividend per Share	1.33	1.37	1.4	1.45	1.49	1.52	1.57	1.6	1.57	1.8	2.04	2.18	2.29	2.4	2.48
Cash Flow per Share	2.85	4.16	2.16	1.9	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Free Cash Flow per Basic Share	2.63	3.83	1.83	1.58	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Cash & Equivalents per Share	5.18	1.74	2.76	4.5	2.57	3.82	4.19	5.39	6.91	7.41	8	4.46	6.08	5.35	5.24
Book Value per Share	9.47	8.36	9.23	8.98	8.59	9.72	7.23	8.64	23.16	17.03	16.7	14.97	14.56	8.05	9.07
Tangible Book Value per Share	4.3	-1.71	3.5	3.67	3.59	4.76	2.26	3.94	-15.65	-16.29	-12.69	-12.74	-9.51	-14.31	-11.12

Bristol-Myers Squibb Company

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)